You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Acne Vaccines Targeting a Surface Sialidase and a Secreted CAMP Factor Toxin

    SBC: VAXIN INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Propionibacterium acnes (P. acnes) is most notably recognized for its role in acne vulgaris, the most common skin disease, affecting 85-100% of the population at some point in their lives. Current treatments for vulgari s acne using isotretinoin (13-cis-retinoic acid) or antibiotics can have many undesirable effects, including depression, teratogenicity, hormon ...

    STTR Phase I 2008 Department of Health and Human ServicesNational Institutes of Health
  2. ActiveImplant Prosthesis for Lower Limb Amputees

    SBC: Simbex LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This goal of this SBIR project is to quantify the feasibility and potential for an implantable prosthetic device at the distal end of the cut bone for above-knee (AK) amputees. It is hypothesized that such a device can significantly improve residual limb tissue health and load distribution within the prosthetic socket leading to a dramatic improvement in the f ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  3. ActiveStep Fall Prevention Training System

    SBC: Simbex LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Falls are a leading cause of injury and mortality in the elderly. Ongoing research using the ActiveStep treadmill completed in Phase I/Phase II, has demonstrated that a treadmill-based perturbation tool for tripping and slipping has demonstrated a positive effect on the biomechanical performance of older adults subject to laboratory induced trip and slip distu ...

    SBIR Phase II 2007 Department of Health and Human ServicesNational Institutes of Health
  4. Adenovirus vectored vaccines for Alzheimer's disease

    SBC: VAXIN INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Alzheimer disease (AD) is the most common neurodegenerative disease in the elderly. To date, no satisfactory treatment is available for AD. One of the pathological hallmarks of AD is deposits of amyloid protein (Aa) in neuritic plaques and cerebral vessels. Increasing lines of evidence support the notion that Aa and its precursor (APP) play pathogenetic roles i ...

    STTR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  5. A Device to Monitor Toe Walking in Children with Cerebral Palsy

    SBC: Simbex LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This goal of this SBIR project is to quantify and validate the feasibility and potential for a non- obtrusive, wearable, in-shoe gait-monitoring device for children with Cerebral Palsy (CP). It is hypothesized that continuous monitoring and analysis of simple gait parameters in children with CP outside the clinical laboratory and during normal daily activities ...

    SBIR Phase II 2008 Department of Health and Human ServicesNational Institutes of Health
  6. A Device to Monitor Toe Walking in Children with Cerebral Palsy

    SBC: Simbex LLC            Topic: N/A

    DESCRIPTION (provided by applicant): This goal of this SBIR project is to quantify and validate the feasibility and potential for a non- obtrusive, wearable, in-shoe gait-monitoring device for children with Cerebral Palsy (CP). It is hypothesized that con tinuous monitoring and analysis of simple gait parameters in children with CP outside the clinical laboratory and during normal daily activitie ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  7. An Aerosol Device for Measles Vaccination (B)

    SBC: CREARE LLC            Topic: NA

    N/A

    SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  8. A Novel Liquid Oxygen Recharger for Home Oxygen Therapy

    SBC: CREARE LLC            Topic: N/A

    DESCRIPTION (provided by applicant): The specific aim of this research program is to develop and transition a low-cost, liquid oxygen (LOX) generation system to support ambulatory patients using Home Oxygen Therapy (HOT). Currently in the United States, yearly expenditures on HOT are nearly two billion dollars. These expenditures will increase dramatically over the next 10 years due to the aging ...

    SBIR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  9. A novel therapy for sepsis

    SBC: BIOPOWERTECH            Topic: N/A

    Description: (Provided by Applicant) Sepsis a serious life-threatening condition resulting from a harmful inflammatory reaction of the body due to bacterial infection. The mortality rate of sepsis remains high in intensive care units around the world but therapeutic interventions have been largely unsuccessful. Clearly, there is a great need for inventing efficacious therapeutic drugs to treat pat ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
  10. A Shielded Conditionally Replicative Adenoviral Vector

    SBC: VECTORLOGICS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Conditionally replicative adenovirus vectors (CRAds) are novel vectors with utility as virotherapy agents for alternative cancer therapies. These vectors already have established a broad safety record in humans. However, two confounding problems limit efficacy of these drug candidates, the paucity of the native Ad receptor on tumor tissues, and host humoral res ...

    SBIR Phase I 2007 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government